Paul Thorn
Medical · Rockville, MDNPI 1992816482
Payments from drug & device makers
Across 93 payments — averaging $19.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$398
- Novo Nordisk$240
- GSK$189
- Pfizer$157
- Amgen$152
- Boehringer Ingelheim$98
- plus $579 from 14 others
What the payments were for
- Food & beverage$1,813100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 22 | $398 |
| Novo Nordisk | 13 | $240 |
| GSK | 10 | $189 |
| Pfizer | 8 | $157 |
| Amgen | 8 | $152 |
| Boehringer Ingelheim | 4 | $98 |
| Astellas Pharma US Inc | 4 | $94 |
| Gilead | 5 | $90 |
| AstraZeneca | 3 | $69 |
| Lilly USA, LLC | 3 | $61 |
| Exact Sciences | 2 | $44 |
| Merck | 2 | $40 |
| Sanofi Pasteur Inc. | 2 | $40 |
| Inspire Medical Systems, Inc. | 1 | $32 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| Abbott | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
How this compares
$1,813 in reported general payments places this provider in the 70th percentile of 543 medical providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 17 | $12,562 |
| Atorvastatin Calcium | 52 | $676 |
| Valsartan | 15 | $600 |
| Esomeprazole Magnesium | 16 | $461 |
| Amlodipine Besylate | 45 | $414 |
| Levothyroxine Sodium | 37 | $412 |
| Simvastatin | 26 | $385 |
| Metoprolol Succinate | 12 | $276 |
| Metformin Hcl | 33 | $254 |
| Lisinopril | 28 | $225 |
| Losartan Potassium | 17 | $210 |
| Glipizide ErGlipizide | 14 | $135 |
| Paroxetine Hcl | 14 | $81 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $98 | $12,56217 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 543 medical providers in Maryland.
Other medical in Rockville
- Adrienne DuncanRockville$9K
- Jennifer SchaefferRockville$8K
- Victoria TrottStevensville$94K
- Sarah SagorskyBaltimore$68K
- Emily GrisnikLeonardtown$62K
- Jennifer HamiltonBel Air$52K
- Kristina TrunnellFrederick$51K
- Karen ScottAnnapolis$49K
- Nicholas WunderAberdeen$40K
- Sarah JamiesonFrederick$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.